Home | Products | R&D | About Us | Contact Us

Nuraging Product Range

Nuraging Research and Development

About Nuraging Biotech

Nuraging Biotech Contact Details

 

 

 

 

 

 

Nutraceuticals Research

Pharmaceuticals Research

 

Our facilities are part of the Sardinian Research, Development and Technology facilities in Pula

(www.sardegnaricerche.it)

 

 

RESEARCH AND DEVELOPMENT

Our Working Hypothesis

•  Among the biological processes of aging, the decreased ability to deal with metabolic stress seems to be of particular importance. Aging is a chronic stressful state.

•  In humans, brain age-related alterations are mainly caused by metabolic oxidative stress  processes, particularly affecting the hippocampal pyramidal neurons.

•  The hippocampus is part of the limbic system and exerts an important  influence on the activity of the hypothalamus-pituitary-adrenal (HPA) axis.

•  The hippocampus plays a key role in the regulation of stress-induced corticosteroid secretion

•  The hippocampus is also a basic structure for social life, being involved in memory, learning, mood regulation.

•  Hippocampal aging induces a dysfunction of the HPA axis, characterised by a state of hyperadrenoglucocorticism.

•  Excess corticoid receptor activation mediates neuronal degeneration through an increased influx of calcium into the cells, by an increased release of excitatory amino acids glutamic acid, kainic acid coupled with a decreased level of inhibitory amino acids GABA, glycine, taurine

•  Hyperadrenoglucocorticism can be easily detected by a simple clinical marker, i.e. the non-response to the dexamethasone suppression-test.

•  The consequences of hyperadrenoglucocorticism may include  hyperglycaemia, hyperlipidaemia, atherosclerosis, immunosuppression, centralisation of fat mass, osteoporosis, muscle atrophy, fatigue syndrome, mood disturbances, disturbances of higher cognitive function, particularly memory.

•  NRA is developing a combination of active nutrient products (IP protected) aimed at counteracting the process of hippocampal aging and its physiopathological cascade of events induced by oxidative stress processes;

  • Memory, attention disturbances : NURAX MEMORY
  • Muscle atrophy, mood disturbances, fatigue: NURAX ENERGY
  • Osteoarthrosis, Joint inflammation: NURAX FLEX
  • Hyperglycemia, hyperlipidemia: (NEXT NURAX GENERATION)

Nutraceuticals

•  Screening and Research on Sardinian Medicinal Flora

•  Partnership with Cosmese, Italy

•  Partnership with PharmaNess, Italy

•  In-house Development of NURAX Products

•  First generation NURAX products already commercialised

•  Second generation under development (purified and titrated extracts; new blends of IP protected extracts)

•  Out-Licensing of Products to International Partners

•  Further R&D characterisation

•  International Marketing

Pharmaceuticals

•  Magnesium/Zinc Salts products

•  Co-development with Tri-InoV SARL, France

•  Potential Indication: Age-related Macular Degeneration

•  Unsaturated Long Chain Fatty Acid products

•  Co-Development with Croda Ltd. UK

•  Potential Indications: Multiple Sclerosis; Peripheral Neuropathies

•  Drug Delivery Platforms

•  Proprietary NRA Technology (under development)

 

 

Home | Products | R&D | About Us | Contact Us